Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD – LANZAJET’S FLAGSHIP UK SAF PLANT
CHICAGO, Nov. 4, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…
Edesa Biotech Announces Upcoming Conference Schedule
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a…
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025 16:30 ET | Source: FibroBiologics, Inc. Advancing preparations to…
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001…
Bright Minds Biosciences toPresent at Upcoming Conferences
October 30, 2025 18:30 ET | Source: Bright Minds Biosciences NEW YORK,…
CORRECTION Micron Announces Participation in Investor Event
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued…
CATALYX SPACE SECURES $5.4 MILLION SEED ROUND TO BUILD FOR THE NEXT ERA OF ORBITAL LOGISTICS
Catalyx is building the complete back-end infrastructure for space: hardware, software, and…